Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Ansell

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
Journal of Thrombosis and Thrombolysis|February 2, 2013
Point-of-care patient self-monitoring of oral vitamin K antagonist therapyJack Ansell
Journal of Thrombosis and Thrombolysis|July 19, 2013
The new oral anticoagulants: results of clinical trials and practical applicationsJack Ansell
Expert Review of Cardiovascular Therapy|July 21, 2015
Is there a need for an alternative in the era of novel anticoagulants?Jack Ansell
Hematology. American Society of Hematology. Education Program|January 18, 2011
Warfarin versus new agents: interpreting the dataJack Ansell
Thrombosis and Haemostasis|March 23, 2012
Will the new target-specific oral anticoagulants improve the treatment of venous thromboembolism?Jack Ansell
Journal of the American Heart Association|July 25, 2017
Stroke Prevention in Atrial Fibrillation in the Very Elderly: Anticoagulant Therapy Is No Longer a SinJack Ansell
Journal of General Internal Medicine|March 27, 2009
Personalizing health care--is this the right time for warfarin?Jack Ansell
Nature Medicine|April 6, 2013
Blocking bleeding: reversing anticoagulant therapyJack Ansell
Primary Care|February 14, 2013
The evolution of oral anticoagulant therapyChristopher Dittus, Jack Ansell
Therapeutic Advances in Chronic Disease|December 20, 2012
New anticoagulants in atrial fibrillation: an update for cliniciansSatjit Bhusri, Jack Ansell
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Journal of Thrombosis and Thrombolysis|February 2, 2013
Point-of-care patient self-monitoring of oral vitamin K antagonist therapyJack Ansell
Journal of Thrombosis and Thrombolysis|July 19, 2013
The new oral anticoagulants: results of clinical trials and practical applicationsJack Ansell
Expert Review of Cardiovascular Therapy|July 21, 2015
Is there a need for an alternative in the era of novel anticoagulants?Jack Ansell
Hematology. American Society of Hematology. Education Program|January 18, 2011
Warfarin versus new agents: interpreting the dataJack Ansell
Thrombosis and Haemostasis|March 23, 2012
Will the new target-specific oral anticoagulants improve the treatment of venous thromboembolism?Jack Ansell
Journal of the American Heart Association|July 25, 2017
Stroke Prevention in Atrial Fibrillation in the Very Elderly: Anticoagulant Therapy Is No Longer a SinJack Ansell
Journal of General Internal Medicine|March 27, 2009
Personalizing health care--is this the right time for warfarin?Jack Ansell
Nature Medicine|April 6, 2013
Blocking bleeding: reversing anticoagulant therapyJack Ansell
Primary Care|February 14, 2013
The evolution of oral anticoagulant therapyChristopher Dittus, Jack Ansell
Therapeutic Advances in Chronic Disease|December 20, 2012
New anticoagulants in atrial fibrillation: an update for cliniciansSatjit Bhusri, Jack Ansell
Pageof 12